(Q56778458)

English

Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study

article by Denis C Talbot et al published 15 December 2010 in Clinical Cancer Research

Statements

Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose study (English)
0 references
0 references
0 references
Denis C Talbot
0 references
Malcolm Ranson
0 references
Joanna Davies
0 references
Michael Lahn
0 references
Sophie Callies
0 references
Valérie André
0 references
Sunil Kadam
0 references
Michael Burgess
0 references
Christopher Slapak
0 references
Anna L Olsen
0 references
Johann S de Bono
0 references
Azeem Saleem
0 references
Patricia Price
0 references
15 December 2010
0 references
16
0 references
24
0 references
6150-8
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit